1 – 10 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Impact of Drug Induced Remission in Rheumatoid Arthritis
- The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale : Validation in six countries
- 2017
- Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
- Arthritis management in primary care - A study of physiotherapists' current practice, educational needs and adherence to national guidelines
- The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
- The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis
- Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA
- Severe extraarticular manifestations in a community based cohort of patients with rheumatoid arthritis : Risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors
- Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
- Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine